SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : Axcelis Technologies, Inc. (ACLS)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Big Dog who wrote (40)7/29/2000 8:56:38 PM
From: TomT   of 195
 
Check out www.iionline.com where they talk about great recent IPOs. Listed below is section talking about ACLS

Axcelis Technology (NASDAQ:ACLS - Quotes, News, Boards) looks to be the slam dunk of the IPO pack. The company's July 11 IPO was priced at $22 and was met with strong demand. On its first day, the stock rose to $30 on an intra-day basis. But it's been downhill from there, and the stock has fallen down to $16.56.

Even a strong second quarter failed to lift the shares. Sales for semiconductor capital equipment maker rose 68% year-over-year and 16% sequentially to $99 million. Profits of $0.27 a share were quite respectable. The company specializes in ion implantation equipment used to make semiconductors and is currently a wholly owned subsidiary of Eaton Corporation (NYSE:ETN - Quotes, News, Boards).

Following the offering, Eaton still owns about 83.8% of Axcelis' outstanding common stock, and will divest the remainder in about six months.

Judging by the results of the competition, demand in the sector looks pretty strong. Varian Semiconductor Equipment Associates (NASDAQ: VSEA - Quotes, News, Boards) just released third quarter profits well ahead of expectations.

The net rose to $0.81 per share against a consensus estimate of $0.63 per share, and an $0.11 per share loss last year. Third quarter revenue reached $192 million, up 202% from last year's $63 million, and higher by 23% sequentially.

Axcelis looks pretty cheap when compared to competitors such as Varian Semiconductor. Varian trades for 26 times its September 2000 fiscal year earnings estimates. In contrast, Axcelis trades for 16 times its estimate for the current fiscal year. Underwriter Goldman Sachs is sure to point that out when it initiates coverage around August 10.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext